Thymosin alpha-1 therapy improves postoperative survival after curative resection for solitary hepatitis B virus-related hepatocellular carcinoma: A propensity score matching analysis

Thymosin alpha-1 (Tα1) is an immunomodulatory and antiviral agent with potential effects on chronic hepatitis B and liver cancer. Its impact on solitary hepatocellular carcinoma (HCC) remains controversial, so we aimed to investigate the efficacy of Tα1 in solitary HBV-related HCC patients after cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Linye, He, Zijing, Xia, Wei, Peng, Chao, He, Chuan, Li, Tianfu, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137107/
https://www.ncbi.nlm.nih.gov/pubmed/34011034
http://dx.doi.org/10.1097/MD.0000000000025749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137107/
https://www.ncbi.nlm.nih.gov/pubmed/34011034
http://dx.doi.org/10.1097/MD.0000000000025749

Ejemplares similares